- Presentations
- 4
- Markets
- 1
Avtozma is a brand of Tocilizumab marketed by Celltrion, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Tocilizumab
- Brand owner
- Celltrion
- Registered in
- United States
- Strengths and forms
- 162 mg/0.9 mL injection, 200 mg/10 mL injection, 400 mg/20 mL injection, 80 mg/4 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Avtozma 162 mg/0.9 mL injectionSubcutaneous Cold chain | Celltrion | US FDA | Available on request |
| Avtozma 200 mg/10 mL injectionIntravenous Cold chain | Celltrion | US FDA | Available on request |
| Avtozma 400 mg/20 mL injectionIntravenous Cold chain | Celltrion | US FDA | Available on request |
| Avtozma 80 mg/4 mL injectionIntravenous Cold chain | Celltrion | US FDA | Available on request |
Equivalent brands
Other brands of Tocilizumab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Avtozma
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.